Cargando…

The Soluble Plasminogen Activator Receptor as a Biomarker on Monitoring the Therapy Progress of Pulmonary TB-AFB(+) Patients

The role of soluble soluble urokinase-type plasminogen activator receptor (suPAR) as a biological marker for TB treatment efficacy on active pulmonary TB-AFB(+) patients was investigated. Twenty pulmonary TB-AFB(+) patients participated in a cohort study for six months. The plasma suPAR level was me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mardining Raras, Tri Yudani, Noor Chozin, Iin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335589/ https://www.ncbi.nlm.nih.gov/pubmed/22567258 http://dx.doi.org/10.1155/2010/406346

Ejemplares similares

Soluble Urokinase Plasminogen Activator Receptor Levels in Tuberculosis Patients at High Risk for Multidrug Resistance
por: Mardining Raras, Tri Yudani, et al.
Publicado: (2012)

IMMUNE RESPONSE UPON THE ADMINISTRATION OF RECOMBINANT PROTEIN ANTIBODIES Ag-38 KDa Mycobacterium tuberculosis AND RIFAMPICIN EX-VIVO
por: Raras, Tri Yudani Mardining, et al.
Publicado: (2022)

Extra Virgin Olive Oil Modulates Vasodilator Enzyme Level by Repairing Angiogenesis Function in Rat Model of Preeclampsia
por: Silvani, Yulia, et al.
Publicado: (2020)

Redesigning Primer of ITS2 (Internal Transcribed Spacer 2) for Specific Molecular Characterization of Malaria Vectors Anopheles Species
por: Senjarini, Kartika, et al.
Publicado: (2021)

The levels of pro-fibrotic cytokines in pulmonary tuberculosis with minimal and extensive lesions
por: Astuti, Triwahju, et al.
Publicado: (2018)

GENERATING RESPONSES IMMUNE IN CELLULAR AND HUMORAL TREATMENT WITH EPITOPE SPIKE, EPITOPE ENVELOPE PROTEIN, AND EPITOPE MEMBRANE PROTEIN SARS-COV-2, HONEY, SAUSSUREA LAPPA, AND NIGELLA SATIVA
por: Prawiro, Sumarno Reto, et al.
Publicado: (2021)

Comparison of acid fast bacilli (AFB) smear for Mycobacterium tuberculosis on adult pulmonary tuberculosis (TB) patients with type 2 diabetes mellitus (DM) and without type 2 DM
por: Fachri, Muhammad, et al.
Publicado: (2018)

Pulmonary Immune-Compartment-Specific Interferon Gamma Responses in HIV-Infected Individuals with Active Tuberculosis (TB) in an Area of High TB Prevalence
por: Buldeo, S., et al.
Publicado: (2012)

Evaluation of an AI-Based TB AFB Smear Screening System for Laboratory Diagnosis on Routine Practice
por: Fu, Hsiao-Ting, et al.
Publicado: (2022)

QCD corrections to Afb(b) and Afb(c) measurements at LEP I
por: CERN. Geneva. ALEPH
Publicado: (1997)

Negative regulation of seed germination by maternal AFB1 and AFB5 in Arabidopsis
por: Wang, Yixing, et al.
Publicado: (2022)

Nutrition Status Related to Clinical Improvement in AFB-Positive Pulmonary Tuberculosis Patients in Primary Health Centres in Medan, Indonesia
por: Sari, Dina Keumala, et al.
Publicado: (2019)

Image processing for AFB segmentation in bacilloscopies of pulmonary tuberculosis diagnosis
por: Díaz-Huerta, Jorge Luis, et al.
Publicado: (2019)

AFB(b) Status of Results
por: Ciulli, Vitaliano
Publicado: (2002)

A_FB met LHC
por: Aguilar Saavedra, Juan Antonio
Publicado: (2011)

Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD
por: Sommerer, Claudia, et al.
Publicado: (2023)

Sputum AFB in tuberculous pleural effusion
por: Wiwanitkit, Viroj
Publicado: (2011)

Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer
por: Okugawa, Y, et al.
Publicado: (2010)

A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression
por: Levine, Todd D., et al.
Publicado: (2012)

The Arabidopsis Auxin Receptor F-Box Proteins AFB4 and AFB5 Are Required for Response to the Synthetic Auxin Picloram
por: Prigge, Michael J., et al.
Publicado: (2016)

Soluble Urokinase Plasminogen Activator Receptor as a Diagnostic and Prognostic Biomarker in Cardiac Disease
por: Velissaris, Dimitrios, et al.
Publicado: (2021)

Melatonin attenuates AFB1-induced cardiotoxicity via the NLRP3 signalling pathway
por: Yan, Hui, et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients
por: Torino, Claudia, et al.
Publicado: (2018)

Recombinant Expression of Trametes versicolor Aflatoxin B(1)-Degrading Enzyme (TV-AFB(1)D) in Engineering Pichia pastoris GS115 and Application in AFB(1) Degradation in AFB(1)-Contaminated Peanuts
por: Yang, Peizhou, et al.
Publicado: (2021)

An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2012)

Plasma Plasminogen Activator Inhibitor-1 Is Associated with End-Stage Proliferative Diabetic Retinopathy in the Northern Chinese Han Population
por: Zhong, Ze-Long, et al.
Publicado: (2012)

Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients
por: Liu, Xin-ran, et al.
Publicado: (2023)

Measurements of R_b, AFB_b, and AFB_c in e+e- Collisions at 130-183 GeV with the OPAL Detector at LEP
por: CERN. Geneva
Publicado: (1998)

Intraocular Lens Opacification following Intracameral Injection of Recombinant Tissue Plasminogen Activator to Treat Inflammatory Membranes after Cataract Surgery
por: Fung, Simon S. M., et al.
Publicado: (2015)

Increased circulating soluble urokinase-type plasminogen activator receptor (suPAR) levels in patients with slow coronary flow
por: Emrah, Acar, et al.
Publicado: (2016)

Soluble urokinase plasminogen activation receptor - An emerging new biomarker of cardiovascular disease and critical illness
por: Cyrille, Nicole B., et al.
Publicado: (2016)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2021)

Soluble urokinase plasminogen activator receptor: from biomarker to active participant in atherosclerosis and cardiovascular disease
por: Goodchild, Traci T., et al.
Publicado: (2022)

A Pilot Study of Urokinase-Type Plasminogen Activator (uPA) Overexpression in the Brush Cytology of Patients with Malignant Pancreatic or Biliary Strictures
por: Gibbs, John F., et al.
Publicado: (2009)

Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial
por: Chen, Ray Y., et al.
Publicado: (2017)

TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB – a study protocol
por: Rachow, Andrea, et al.
Publicado: (2019)

The relationship between vitamin D level and second acid-fast bacilli (AFB) smear-positive during treatment for TB patients was inferred by Bayesian network
por: Zhang, Xiaoxu, et al.
Publicado: (2022)

Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD
por: Gumus, Aziz, et al.
Publicado: (2015)

From lactate to soluble urokinase plasminogen activator receptor: The journey for ideal cardiac biomarker: Are we there in 2016?
por: Kapoor, Poonam Malhotra
Publicado: (2016)

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
por: Koh, Angela S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8oijc4k1utp2tk6s57u15ba8m0